• 1. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 2. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 3. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 4. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 5. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577

Comprehensive Overview of (6-Methoxypyridin-2-yl)methanamine Dihydrochloride (CAS No. 2172852-89-8)

(6-Methoxypyridin-2-yl)methanamine dihydrochloride (CAS No. 2172852-89-8) is a specialized organic compound that has garnered significant attention in pharmaceutical and biochemical research. This compound, characterized by its pyridine backbone and methoxy functional group, serves as a versatile intermediate in the synthesis of bioactive molecules. Its unique structural properties make it valuable for drug discovery, particularly in targeting central nervous system (CNS) disorders and enzyme modulation.

The growing interest in (6-Methoxypyridin-2-yl)methanamine dihydrochloride aligns with current trends in precision medicine and small-molecule therapeutics. Researchers are increasingly exploring its potential in designing selective kinase inhibitors and neurotransmitter analogs, addressing conditions like neurodegenerative diseases and metabolic syndromes. Its dihydrochloride salt form enhances solubility, a critical factor for in-vivo bioavailability studies.

From a synthetic chemistry perspective, the compound’s methoxypyridine moiety offers reactivity advantages for cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings. These reactions are pivotal in constructing complex heterocyclic scaffolds, a hot topic in medicinal chemistry forums. The CAS No. 2172852-89-8 is frequently cited in patent literature, underscoring its industrial relevance.

Environmental and green chemistry considerations also drive innovations around this compound. Recent publications highlight its role in catalysis and sustainable synthesis, aligning with the demand for eco-friendly pharmaceutical processes. Analytical techniques like HPLC and LC-MS are commonly employed to validate its purity, a key concern for GMP-compliant production.

In summary, (6-Methoxypyridin-2-yl)methanamine dihydrochloride exemplifies the intersection of structural ingenuity and therapeutic potential. Its applications span drug development, material science, and catalytic research, making it a compound of enduring scientific and commercial interest.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)